TME NORMALIZATION
DEAD

Serial Number

90813957

Owner

Immix Biopharma, Inc.

Attorney

Sheila R. Gibson

Filing Date

Jul 6, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TME NORMALIZATION Trademark

Serial Number: 90813957

TME NORMALIZATION is a trademark filed by Immix Biopharma, Inc. on July 6, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Immix Biopharma, Inc. (7 trademarks)

10573 W. Pico Blvd #58
Los Angeles, CA 90064

Entity Type: 03

Trademark Details

Filing Date

July 6, 2021

Registration Date

Not Registered

Goods & Services

Tumor suppressing agents; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
May 4, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
May 4, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 16, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 16, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 14, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2022 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 10, 2022 CHAN
ASSIGNED TO LIE
Nov 10, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 29, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 29, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 29, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 24, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2021 NWOS
NEW APPLICATION ENTERED
Jul 9, 2021 NWAP